PTC is committed to bringing hope to patients with rare and genetic diseases.
Our scientists are finding new ways to regulate biology to control disease.
We are developing new treatments for Duchenne Muscular Dystrophy, Cystic Fibrosis and other diseases.
Translating Science. Transforming Lives.
View Our Pipeline
Careers at PTC
PTC STRIVE Awards Program
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Announces Closing of $150 Million of Convertible Senior Notes
PTC Therapeutics Announces Pricing of $125 Million of Convertible Senior Notes
View all latest news